Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Slos

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
FEMS Microbiology Letters|December 16, 1998
Production of cholera toxin B subunit in LactobacillusP Slos, P Dutot, J Reymund, et al.
Research in Immunology|December 16, 1998
Cancer immunotherapy by direct in vivo transfer of immunomodulatory genesP Leroy, P Slos, H Homann, et al.
Gene Therapy|August 6, 2003
Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cellsG G Hillman, N L Kallinteris, J Li, et al.
Cancer Gene Therapy|April 8, 2003
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanomaAlok A Khorana, J D Rosenblatt, D M Sahasrabudhe, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
FEMS Microbiology Letters|December 16, 1998
Production of cholera toxin B subunit in LactobacillusP Slos, P Dutot, J Reymund, et al.
Research in Immunology|December 16, 1998
Cancer immunotherapy by direct in vivo transfer of immunomodulatory genesP Leroy, P Slos, H Homann, et al.
Gene Therapy|August 6, 2003
Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cellsG G Hillman, N L Kallinteris, J Li, et al.
Cancer Gene Therapy|April 8, 2003
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanomaAlok A Khorana, J D Rosenblatt, D M Sahasrabudhe, et al.
Pageof 2